Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury

Clinical Immunology

Volumn 143, Issue 2, 2012, Pages 116-127

  Hofmann, S R ^a   Rosen Wolff A ^a   Tsokos, G C ^b   Hedrich, C M ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; IL 10; IL 19; IL 20; IL 24; Tissue injury

Indexed keywords

CALCIPOTRIOL; CHEMOKINE; CONCANAVALIN A; CXCL1 CHEMOKINE; CXCL7 CHEMOKINE; CXCL9 CHEMOKINE; CYCLOSPORIN A; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 20 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; RANTES; RNA POLYMERASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME; CHRONIC NON BACTERIAL OSTEOMYELITIS; COLITIS; CROHN DISEASE; ENTERITIS; EPITHELIUM CELL; FIBROBLAST; GENE CONTROL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIA; JUVENILE RHEUMATOID ARTHRITIS; KERATINOCYTE; KUPFFER CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MELANOCYTE; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OSTEOMYELITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; ULCERATIVE COLITIS; UNSTABLE ANGINA PECTORIS; WOUND HEALING;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; WOUNDS AND INJURIES;

EID: 84859777122     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.02.005     Document Type: Review

References (116)

1. Commins S., Steinke J.W., Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J. Allergy Clin. Immunol. 2008, 121:1108-1111.
2. + T lymphocytes and macrophages: effects on tissue-specific gene expression. Klin. Padiatr. 2011.
3. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
4. Jones E.A., Flavell R.A. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J. Immunol. 2005, 175:7437-7446.
5. Hedrich C.M., Bream J.H. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 2010, 47:185-206.
6. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
7. Moore K.W., de Waal M.R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
8. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147:3815-3822.
9. D'Andrea A., ste-Amezaga M., Valiante N.M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993, 178:1041-1048.
10. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
11. Mocellin S., Panelli M.C., Wang E., Nagorsen D., Marincola F.M. The dual role of IL-10. Trends Immunol. 2003, 24:36-43.
12. Boulland M.L., Meignin V., Leroy-Viard K., Copie-Bergman C., Briere J., Touitou R., Kanavaros P., Gaulard P. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Am. J. Pathol. 1998, 153:1229-1237.
13. Brightbill H.D., Plevy S.E., Modlin R.L., Smale S.T. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 2000, 164:1940-1951.
14. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., az-Mitoma F., Kumar A. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 2001, 276:13664-13674.
15. Brenner S., Prosch S., Schenke-Layland K., Riese U., Gausmann U., Platzer C. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 2003, 278:5597-5604.
16. Platzer C., Fritsch E., Elsner T., Lehmann M.H., Volk H.D., Prosch S. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 1999, 29:3098-3104.
17. Chang H.D., Helbig C., Tykocinski L., Kreher S., Koeck J., Niesner U., Radbruch A. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 2007, 37:807-817.
18. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., ste-Amezaga M., Frank I., Trinchieri G. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J. Exp. Med. 1996, 183:2559-2569.
19. Grant L.R., Yao Z.J., Hedrich C.M., Wang F., Moorthy A., Wilson K., Ranatunga D., Bream J.H. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun. 2008, 9:316-327.
20. Saraiva M., Christensen J.R., Veldhoen M., Murphy T.L., Murphy K.M., O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009, 31:209-219.
21. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O'Shea J.J., Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
22. + T cells. J. Immunol. 2009, 183:5518-5525.
23. Wang Z.Y., Sato H., Kusam S., Sehra S., Toney L.M., Dent A.L. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J. Immunol. 2005, 174:2098-2105.
24. Cao S., Liu J., Song L., Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J. Immunol. 2005, 174:3484-3492.
25. Wessells J., Baer M., Young H.A., Claudio E., Brown K., Siebenlist U., Johnson P.F. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 2004, 279:49995-50003.
26. + T cell activation; influence of IL-27. Mol. Immunol. 2010, 48:73-81.
27. Im S.H., Hueber A., Monticelli S., Kang K.H., Rao A. Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 2004, 279:46818-46825.
28. Saraiva M., Christensen J.R., Tsytsykova A.V., Goldfeld A.E., Ley S.C., Kioussis D., O'Garra A. Identification of a macrophage-specific chromatin signature in the IL-10 locus. J. Immunol. 2005, 175:1041-1046.
29. Glowacka E., Lewkowicz P., Rotsztejn H., Zalewska A. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. Adv. Med. Sci. 2010, 55:254-260.
30. Byun J.Y., Lee G.Y., Choi H.Y., Myung K.B., Choi Y.W. The expressions of TGF-beta(1) and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann. Dermatol. 2011, 23:19-22.
31. Docke W.D., Asadullah K., Belbe G., Ebeling M., Hoflich C., Friedrich M., Sterry W., Volk H.D. Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of Interleukin-10 application in psoriasis. J. Leukoc. Biol. 2009, 85:582-593.
32. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
33. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 2009, 27:313-338.
34. + regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 2005, 174:7487-7491.
35. Roers A., Siewe L., Strittmatter E., Deckert M., Schluter D., Stenzel W., Gruber A.D., Krieg T., Rajewsky K., Muller W. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 2004, 200:1289-1297.
36. Fowler E.V., Eri R., Hume G., Johnstone S., Pandeya N., Lincoln D., Templeton D., Radford-Smith G.L. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J. Med. Genet. 2005, 42:523-528.
37. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., Domingues F.S., Albrecht M., Nothnagel M., Ellinghaus D., Sina C., Onnie C.M., Weersma R.K., Stokkers P.C., Wijmenga C., Gazouli M., Strachan D., McArdle W.L., Vermeire S., Rutgeerts P., Rosenstiel P., Krawczak M., Vatn M.H., Mathew C.G., Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 2008, 40:1319-1323.
38. Leach M.W., Davidson N.J., Fort M.M., Powrie F., Rennick D.M. The role of IL-10 in inflammatory bowel disease: "of mice and men". Toxicol. Pathol. 1999, 27:123-133.
39. Gambhir D., Lawrence A., Aggarwal A., Misra R., Mandal S.K., Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol. Int. 2010, 30:1211-1217.
40. Paradowska-Gorycka A., Trefler J., iejewska-Stelmach J., Lacki J.K. Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients. Int. J. Immunogenet. 2010, 37:225-231.
41. Ying B., Shi Y., Pan X., Song X., Huang Z., Niu Q., Cai B., Wang L. Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol. Biol. Rep. 2011, 38:379-385.
42. Moller J.C., Paul D., Ganser G., Range U., Gahr M., Kelsch R., Rosen-Wolff A., Hedrich C.M. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin. Exp. Rheumatol. 2010, 28:912-918.
43. Fife M.S., Gutierrez A., Ogilvie E.M., Stock C.J., Samuel J.M., Thomson W., Mack L.F., Lewis C.M., Woo P. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res. Ther. 2006, 8:R148.
44. Dolff S., Abdulahad W.H., Bijl M., Kallenberg C.G. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?. Lupus 2009, 18:575-580.
45. + T cells of patients with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 2010:931018.
46. Hofmann S.R., Schwarz T., Moller J.C., Morbach H., Schnabel A., Rosen-Wolff A., Girschick H.J., Hedrich C.M. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin. Immunol. 2011, 141:317-327.
47. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995, 96:2339-2347.
48. Siewe L., Bollati-Fogolin M., Wickenhauser C., Krieg T., Muller W., Roers A. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur. J. Immunol. 2006, 36:3248-3255.
49. Ishida H., Hastings R., Thompson-Snipes L., Howard M. Modified immunological status of anti-IL-10 treated mice. Cell. Immunol. 1993, 148:371-384.
50. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., De G.D., Abramowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 1994, 24:1167-1171.
51. Scumpia P.O., Moldawer L.L. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit. Care Med. 2005, 33:S468-S471.
52. Standiford T.J., Strieter R.M., Lukacs N.W., Kunkel S.L. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 1995, 155:2222-2229.
53. Erhardt A., Tiegs G. Tolerance induction in response to liver inflammation. Dig. Dis. 2010, 28:86-92.
54. Di M.R., Xiang M., Zaccone P., Leonardi C., Franco S., Meroni P., Nicoletti F. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 1999, 31:75-83.
55. Louis H., Le M.O., Peny M.O., Quertinmont E., Fokan D., Goldman M., Deviere J. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997, 25:1382-1389.
56. Kaur K., Dhingra S., Slezak J., Sharma A.K., Bajaj A., Singal P.K. Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail. Rev. 2009, 14:113-123.
57. Kaur K., Sharma A.K., Dhingra S., Singal P.K. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J. Mol. Cell. Cardiol. 2006, 41:1023-1030.
58. Dhingra S., Sharma A.K., Singla D.K., Singal P.K. p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3524-H3531.
59. Waehre T., Halvorsen B., Damas J.K., Yndestad A., Brosstad F., Gullestad L., Kjekshus J., Froland S.S., Aukrust P. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur. J. Clin. Investig. 2002, 32:803-810.
60. Gallagher G., Dickensheets H., Eskdale J., Izotova L.S., Mirochnitchenko O.V., Peat J.D., Vazquez N., Pestka S., Donnelly R.P., Kotenko S.V. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 2000, 1:442-450.
61. Gallagher G. Interleukin-19: multiple roles in immune regulation and disease. Cytokine Growth Factor Rev. 2010, 21:345-352.
62. Gallagher G., Eskdale J., Jordan W., Peat J., Campbell J., Boniotto M., Lennon G.P., Dickensheets H., Donnelly R.P. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int. Immunopharmacol. 2004, 4:615-626.
63. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., Husain S., Kreindler J.L., Dubin P.J., Pilewski J.M., Myerburg M.M., Mason C.A., Iwakura Y., Kolls J.K. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14:275-281.
64. Huang F., Wachi S., Thai P., Loukoianov A., Tan K.H., Forteza R.M., Wu R. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J. Allergy Clin. Immunol. 2008, 121:1415-1421.
65. Chen P.J., Wei C.C., Wang C., Chen F.W., Hsu Y.H., Chang M.S. Promoter analysis of interleukin 19. Biochem. Biophys. Res. Commun. 2006, 344:713-720.
66. De L.A., Zelante T., D'Angelo C., Zagarella S., Fallarino F., Spreca A., Iannitti R.G., Bonifazi P., Renauld J.C., Bistoni F., Puccetti P., Romani L. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010, 3:361-373.
67. Romer J., Hasselager E., Norby P.L., Steiniche T., Thorn C.J., Kragballe K. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J. Investig. Dermatol. 2003, 121:1306-1311.
68. Pan H., Hong F., Radaeva S., Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 2004, 1:43-49.
69. Azuma Y.T., Matsuo Y., Kuwamura M., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Nakajima H., Karow M., Takeuchi T. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm. Bowel Dis. 2010, 16:1017-1028.
70. Yeh C.H., Cheng B.C., Hsu C.C., Chen H.W., Wang J.J., Chang M.S., Hsing C.H. Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann. Thorac. Surg. 2011, 92:1252-1259.
71. Alanara T., Karstila K., Moilanen T., Silvennoinen O., Isomaki P. Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand. J. Rheumatol. 2010, 39:118-126.
72. Sakurai N., Kuroiwa T., Ikeuchi H., Hiramatsu N., Maeshima A., Kaneko Y., Hiromura K., Nojima Y. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 2008, 47:815-820.
73. Hsing C.H., Chiu C.J., Chang L.Y., Hsu C.C., Chang M.S. IL-19 is involved in the pathogenesis of endotoxic shock. Shock 2008, 29:7-15.
74. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., Eagan M., Foster D., Haldeman B.A., Hammond A., Haugen H., Jelinek L., Kelly J.D., Madden K., Maurer M.F., Parrish-Novak J., Prunkard D., Sexson S., Sprecher C., Waggie K., West J., Whitmore T.E., Yao L., Kuechle M.K., Dale B.A., Chandrasekher Y.A. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001, 104:9-19.
75. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 2001, 167:3545-3549.
76. Parrish-Novak J., Xu W., Brender T., Yao L., Jones C., West J., Brandt C., Jelinek L., Madden K., McKernan P.A., Foster D.C., Jaspers S., Chandrasekher Y.A. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem. 2002, 277:47517-47523.
77. Wang M., Tan Z., Zhang R., Kotenko S.V., Liang P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem. 2002, 277:7341-7347.
78. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 2005, 174:3695-3702.
79. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., Diepolder H., Marquardt A., Jagla W., Popp A., Leclair S., Herrmann K., Seiderer J., Ochsenkuhn T., Goke B., Auernhammer C.J., Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G827-G838.
80. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
81. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., Kasman I., Winer J., Modrusan Z., Danilenko D.M., Ouyang W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 2007, 178:2229-2240.
82. Braat H., Peppelenbosch M.P., Hommes D.W. Interleukin-10-based therapy for inflammatory bowel disease. Expert. Opin. Biol. Ther. 2003, 3:725-731.
83. Ouyang W., Valdez P. IL-22 in mucosal immunity. Mucosal Immunol. 2008, 1:335-338.
84. + myeloid-derived cells in psoriasis: gene regulation and cellular effects. J. Investig. Dermatol. 2006, 126:1590-1599.
85. Hunt D.W., Boivin W.A., Fairley L.A., Jovanovic M.M., King D.E., Salmon R.A., Utting O.B. Ultraviolet B light stimulates interleukin-20 expression by human epithelial keratinocytes. Photochem. Photobiol. 2006, 82:1292-1300.
86. Wolk K., Witte E., Warszawska K., Schulze-Tanzil G., Witte K., Philipp S., Kunz S., Docke W.D., Asadullah K., Volk H.D., Sterry W., Sabat R. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur. J. Immunol. 2009, 39:3570-3581.
87. Yano S., Banno T., Walsh R., Blumenberg M. Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J. Cell. Physiol. 2008, 214:1-13.
88. Otkjaer K., Kragballe K., Johansen C., Funding A.T., Just H., Jensen U.B., Sorensen L.G., Norby P.L., Clausen J.T., Iversen L. IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms. J. Investig. Dermatol. 2007, 127:1326-1336.
89. Baird A.M., Gray S.G., O'Byrne K.J. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS One 2011, 6:e14593.
90. Kingo K., Koks S., Nikopensius T., Silm H., Vasar E. Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes Immun. 2004, 5:117-121.
91. Hsu Y.H., Li H.H., Hsieh M.Y., Liu M.F., Huang K.Y., Chin L.S., Chen P.C., Cheng H.H., Chang M.S. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 2006, 54:2722-2733.
92. Hsieh M.Y., Chen W.Y., Jiang M.J., Cheng B.C., Huang T.Y., Chang M.S. Interleukin-20 promotes angiogenesis in a direct and indirect manner. Genes Immun. 2006, 7:234-242.
93. Li H.H., Cheng H.H., Sun K.H., Wei C.C., Li C.F., Chen W.C., Wu W.M., Chang M.S. Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis. Clin. Immunol. 2008, 129:277-285.
94. Wei C.C., Chang M.S. A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis. Genes Immun. 2008, 9:668-679.
95. Wei C.C., Li H.H., Hsu Y.H., Hsing C.H., Sung J.M., Chang M.S. Interleukin-20 targets renal cells and is associated with chronic kidney disease. Biochem. Biophys. Res. Commun. 2008, 374:448-453.
96. Wegenka U.M., Dikopoulos N., Reimann J., Adler G., Wahl C. The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2. J. Hepatol. 2007, 46(2):257-265.
97. Radaeva S., Sun R., Pan H.N., Hong F., Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004, 39:1332-1342.
98. Wegenka U.M., Dikopoulos N., Reimann J., Adler G., Wahl C. The murine liver is a potential target organ for IL-19, IL-20 and IL-24: type I Interferons and LPS regulate the expression of IL-20R2. J. Hepatol. 2007, 46:257-265.
99. Chen W.Y., Chang M.S. IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J. Immunol. 2009, 182:5003-5012.
100. Jiang H., Lin J.J., Su Z.Z., Goldstein N.I., Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, MDA-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11:2477-2486.
101. Jiang H., Su Z.Z., Lin J.J., Goldstein N.I., Young C.S., Fisher P.B. The melanoma differentiation associated gene MDA-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9160-9165.
102. Kunz S., Wolk K., Witte E., Witte K., Doecke W.D., Volk H.D., Sterry W., Asadullah K., Sabat R. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp. Dermatol. 2006, 15:991-1004.
103. Andoh A., Shioya M., Nishida A., Bamba S., Tsujikawa T., Kim-Mitsuyama S., Fujiyama Y. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunol. 2009, 183:687-695.
104. Wolk K., Kunz S., Asadullah K., Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J. Immunol. 2002, 168:5397-5402.
105. Buzas K., Oppenheim J.J., Zack Howard O.M. Myeloid cells migrate in response to IL-24. Cytokine 2011, 55:429-434.
106. Schaefer G., Venkataraman C., Schindler U. Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells. J. Immunol. 2001, 166:5859-5863.
107. Wong M.T., Ye J.J., Alonso M.N., Landrigan A., Cheung R.K., Engleman E., Utz P.J. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 2010, 88:624-631.
108. Emdad L., Lebedeva I.V., Su Z.Z., Gupta P., Sauane M., Dash R., Grant S., Dent P., Curiel D.T., Sarkar D., Fisher P.B. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of MDA-7/IL-24. Cancer Biol. Ther. 2009, 8:391-400.
109. Kreis S., Philippidou D., Margue C., Behrmann I. IL-24: a classic cytokine and/or a potential cure for cancer?. J. Cell Mol. Med. 2008, 12:2505-2510.
110. Caudell E.G., Mumm J.B., Poindexter N., Ekmekcioglu S., Mhashilkar A.M., Yang X.H., Retter M.W., Hill P., Chada S., Grimm E.A. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 2002, 168:6041-6046.
111. Lebedeva I.V., Emdad L., Su Z.Z., Gupta P., Sauane M., Sarkar D., Staudt M.R., Liu S.J., Taher M.M., Xiao R., Barral P., Lee S.G., Wang D., Vozhilla N., Park E.S., Chatman L., Boukerche H., Ramesh R., Inoue S., Chada S., Li R., De Pass A.L., Mahasreshti P.J., Dmitriev I.P., Curiel D.T., Yacoub A., Grant S., Dent P., Senzer N., Nemunaitis J.J., Fisher P.B. MDA-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (review). Int. J. Oncol. 2007, 31:985-1007.
112. Sahoo A., Lee C.G., Jash A., Son J.S., Kim G., Kwon H.K., So J.S., Im S.H. Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression. J. Immunol. 2011, 186:4098-4109.
113. Tohyama M., Hanakawa Y., Shirakata Y., Dai X., Yang L., Hirakawa S., Tokumaru S., Okazaki H., Sayama K., Hashimoto K. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur. J. Immunol. 2009, 39:2779-2788.
114. He M., Liang P. IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis. J. Immunol. 2010, 184:1793-1798.
115. Chan J.R., Blumenschein W., Murphy E., Diveu C., Wiekowski M., Abbondanzo S., Lucian L., Geissler R., Brodie S., Kimball A.B., Gorman D.M., Smith K., de Waal M.R., Kastelein R.A., McClanahan T.K., Bowman E.P. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 2006, 203:2577-2587.
116. Kragstrup T.W., Otkjaer K., Holm C., Jorgensen A., Hokland M., Iversen L., Deleuran B. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 2008, 41:16-23.